新华制药(000756.SZ)获枸橼酸西地那非口崩片药品注册证书

Group 1 - The core point of the article is that Xinhua Pharmaceutical (000756.SZ) has received approval from the National Medical Products Administration for the registration certificate of Sildenafil Citrate Orally Disintegrating Tablets, which are used to treat erectile dysfunction [1] Group 2 - The approval signifies a potential expansion in the company's product offerings in the pharmaceutical market [1] - Sildenafil Citrate is a well-known medication, and its approval may enhance the company's competitive position in the treatment of erectile dysfunction [1]